An in vivo assay for retrovirally transduced human peripheral T lymphocytes using nonobese diabetic/severe combined immunodeficiency mice

Experimental Hematology

Volumn 33, Issue 1, 2005, Pages 35-41

  Kaneko, Shin ^a   Nagasawa, Toshiro ^a   Nakauchi, Hiromitsu ^b   Onodera, Masafumi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; VIRUS VECTOR;

ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SIMULATION; T LYMPHOCYTE;

ANIMALS; CELL CYCLE; G0 PHASE; GREEN FLUORESCENT PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, ANIMAL; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; MURINE STEM CELL RETROVIRAL VECTOR; MYELOPROLIFERATIVE SARCOMA VIRUS;

EID: 12344307178     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.10.006     Document Type: Article

References (32)

1. R.M. Blaese, K.W. Culver, and A.D. Miller T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years Science 270 1995 475 480
2. C. Bordignon, L.D. Notarangelo, and N. Nobili Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients Science 270 1995 470 475
3. M. Onodera, T. Ariga, and N. Kawamua Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency Blood 91 1998 30 36
4. C. Bonini, G. Ferrari, and S. Verzeletti HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 276 1997 1719 1724
5. P. Tiberghien, C. Ferrand, and B. Lioure Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft Blood 97 2001 63 72
6. E.M. Kang, M. De Witte, and H. Malech Gene therapy-based treatment for HIV-positive patients with malignancies J Hematother Stem Cell Res 11 2002 809 816
7. M. Onodera, D.M. Nelson, and A. Yachie Development of improved adenosine deaminase retroviral vectors J Virol 72 1998 1769 1774
8. + T cell proliferation in HIV-positive patients as a result of CD28 co-stimulation Science 272 1996 1939 1943
9. + T cells in the absence of exogenous feeder cells J Immunol 159 1997 5921 5930
10. K.E. Pollok, H. Hanenberg, and T.W. Noblitt High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments J Virol 72 1998 4882 4892
11. K.E. Pollok, J.C. van der Loo, R.J. Cooper, L. Kennedy, and D.A. Williams Co-stimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus Hum Gene Ther 10 1999 2221 2236
12. V. Dardalhon, S. Jaleco, and C. Rebouissou Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector Blood 96 2000 885 893
13. D. Jahner, H. Stuhlmann, and C.L. Stewart De novo methylation and expression of retroviral genomes during mouse embryogenesis Nature 298 1982 623 628
14. P.M. Challita, and D.B. Kohn Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo Proc Natl Acad Sci U S A 91 1994 2567 2571
15. C.A. Mullen, K. Snitzer, K.W. Culver, R.A. Morgan, W.F. Anderson, and R.M. Blaese Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector Hum Gene Ther 7 1996 1123 1129
16. S. Kaneko, M. Onodera, Y. Fujiki, T. Nagasawa, and H. Nakauchi Simplified retroviral vector GCsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in non-obese diabetic/severe combined immunodeficient mice Hum Gene Ther 12 2001 35 44
17. M. Onodera, A. Yachie, D.M. Nelson, H. Welchlin, R.A. Morgan, and R.M. Blaese A simple and reliable method for screening retroviral producer clones without selectable markers Hum Gene Ther 8 1997 1189 1194
18. A.C. Zubair, S.A. Ali, R.C. Rees, J.R. Goepel, D.A. Winfield, and M.H. Goyns Analysis of the colonization of unirradiated and irradiated SCID mice by human lymphoma and non-malignant lymphoid cells Leuk Lymphoma 22 1996 463 471
19. + T lymphocytes in non-human primates using a gibbon ape leukemia virus-derived retroviral vector Blood 89 1997 1987 1995
20. S. Verzeletti, C. Bonini, and S. Marktel Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors Hum Gene Ther 9 1998 2243 2251
21. C. Berger, C.A. Blau, and T. Clackson CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy Blood 101 2003 476 484
22. J. Gu, M.L. Kuo, A. Rivera, N. Sutkowski, Y. Ron, and J.P. Dougherty A murine model for genetic manipulation of the T cell compartment Exp Hematol 24 1996 1432 1440
23. M. Tary-Lehmann, and A. Saxon Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood J Exp Med 175 1992 503 516
24. + T lymphocytes producing β interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection J Virol 73 1999 10281 10288
25. H. Kaneshima, R. Namikawa, and J.M. McCune Human hematolymohoid cells in SCID mice Curr Opin Immunol 6 1994 327 333
26. J.M. McCune, R. Namikawa, H. Kaneshima, L.D. Shultz, M. Lieberman, and I.L. Weissman The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function Science 241 1988 1632 1639
27. B.E. Torbett, G. Picchio, and D.E. Mosier hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis Immunol Rev 124 1991 139 164
28. M.D. Ianni, A. Terenzi, and F. Falzetti Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice Cancer Gene Ther 9 2002 756 761
29. K.G. Tournoy, S. Depraetere, and R.A. Pauwels Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice Clin Exp Immunol 119 2000 231 239
30. T. Berney, R.D. Molano, and A. Pileggi Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes Transplantation 72 2001 133 140
31. W.R. Drobyski, D. Majewski, and K. Ozker Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment J Immunol 161 1998 2610
32. E. Contassot, E. Robinet, and R. Angonin Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes Bone Marrow Transplant 22 1998 1097